 |
市场调查报告书
商品编码
1629597
HIV 临床试验市场：按阶段、依研究设计、按申办者类型、按适应症、按地区HIV Clinical Trials Market, By Phase, By Study Design, By Sponsor Type, By Indication, By Geography, By Geography |
||||||
预计2024年全球爱滋病毒临床试验市场规模为14.8亿美元，预计2031年将达21.9亿美元，2024年至2031年复合年增长率为5.8%。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年 | 2023年 | 2024年市场规模 | 14.8亿美元 |
| 实际资料 | 2019-2023 | 预测期 | 2024-2031 |
| 预测 2024-2031 年复合年增长率： | 5.80% | 2031年价值预测 | 21.9亿美元 |
全球爱滋病毒临床试验市场的成长是由世界各地正在进行的越来越多的临床试验推动的，这些临床试验旨在开髮用于爱滋病毒治疗和预防的有效治疗方法和疫苗。由于HIV患者数量不断增加，生物製药公司和研究机构正在加大对HIV临床研发活动的投入。此外，人们对临床试验以及私营和政府部门的可用性的认识不断提高正在推动市场扩张。然而，爱滋病毒临床试验的持续时间长、高成本可能是一个挑战。
市场动态
全球爱滋病毒临床试验市场的成长主要是由于全球爱滋病毒感染人数不断增加，对先进治疗方案的需求不断增长。根据联合国爱滋病规划署的资料，2020年6月，全球约有3,800万人感染爱滋病毒。这种广泛的患者基础正在鼓励製药公司透过临床研究积极投资爱滋病毒疫苗和药物开发。世界卫生组织、比尔及梅琳达盖兹基金会和国际药品采购机制等组织增加爱滋病毒临床研究的私人和公共资金可能会推动市场成长。例如，2020年11月，美国过敏和感染疾病研究所为美国的HIV临床研究提供了大笔津贴。然而，与临床试验相关的较长时间和较高成本可能会阻碍市场成长。此外，与病人安全相关的监管障碍和伦理问题可能会阻碍爱滋病毒临床试验市场的成长。中国和印度等新兴国家由于临床研究成本低廉，可能在不久的将来为市场相关人员创造利润丰厚的机会。
本研究的主要特点
本报告对全球HIV临床试验市场进行了详细分析，并提供了以2023年为基准年的预测期（2024-2031）的市场规模和年复合成长率（CAGR%）。
它还揭示了各个细分市场的潜在商机，并解释了该市场中有吸引力的投资提案的矩阵。
它还提供市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、吉利德科学公司、艾伯维公司、百时美施贵宝公司、葛兰素史克公司、辉瑞公司、罗氏控股公司、赛诺菲公司、诺华公司、安斯泰来製药公司、勃林格殷格翰有限公司、福泰製药公司、安进公司Inc.、武田药品工业株式会社等主要企业采取的竞争策略。
该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
全球爱滋病毒临床试验市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
相关人员可以透过用于分析全球爱滋病毒临床试验市场的各种策略矩阵来促进他们的决策。
目录
第一章 研究目的与前提
- 研究目的
- 先决条件
- 简称
第二章 市场展望
- 报告说明
- 市场定义和范围
- 执行摘要
第三章 市场动态、法规与趋势分析
- 市场动态
第四章 全球 HIV 临床试验市场，依阶段，2019-2031
- 第一阶段
- 第二阶段
- 第三阶段
- 第四阶段
- 临床前
第五章 全球 HIV 临床试验市场（依试验设计），2019-2031 年
- 干预研究
- 观察性研究
- 扩大访问研究
第六章 全球 HIV 临床试验市场，依申办者类型划分，2019-2031 年
- 製药和生物技术公司
- 学术研究所
- 政府和私人研究机构
- 受託研究机构（CRO）
第七章 全球 HIV 临床试验市场（按适应症），2019-2031 年
- HIV-1
- HIV-2
第八章全球爱滋病毒临床试验市场（按地区），2019-2031
- 北美洲
- 拉丁美洲
- 欧洲
- 亚太地区
- 中东
- 非洲
第9章 竞争格局
- Gilead Sciences, Inc.
- Johnson & Johnson
- Merck & Co., Inc.
- AbbVie Inc.
- Bristol-Myers Squibb Company
- GlaxoSmithKline plc
- Pfizer Inc.
- Roche Holding AG
- Sanofi SA
- Novartis AG
- Astellas Pharma Inc.
- Boehringer Ingelheim GmbH
- Vertex Pharmaceuticals Incorporated
- Amgen Inc.
- Takeda Pharmaceutical Company Limited
第10章分析师建议
- 命运之轮
- 分析师观点
- 一致的机会图
第十一章 参考文献与调查方法
- 参考
- 调查方法
- 关于出版商
Global HIV clinical trials market is estimated to be valued at USD 1.48 Bn in 2024 and is expected to reach USD 2.19 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.8% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 1.48 Bn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 5.80% | 2031 Value Projection: | US$ 2.19 Bn |
Global HIV clinical trials market growth is driven by rising number of clinical studies conducted worldwide to develop effective therapies and vaccines for HIV treatment and prevention. Biopharmaceutical companies and research organizations are increasingly investing in HIV clinical research and development activities due to growing HIV patient population. Furthermore, increasing awareness regarding clinical trials and availability of government as well as private can aid the market expansion. However, long durations and high costs associated with HIV clinical studies can pose challenges.
Market Dynamics
Global HIV clinical trials market growth is primarily driven by growing need for advanced treatment options due to increasing prevalence of HIV infections worldwide. In June 2020, as per UNAIDS data, around 38 million people lived with HIV globally in 2020. This wide patient base encourages pharmaceutical players to invest aggressively in HIV vaccine and drug development through clinical research. Rising private and public funding for HIV clinical studies from organizations like WHO, Bill & Melinda Gates Foundation, and UNITAID can drive the market growth. For instance, in November 2020, the National Institute of Allergy and Infectious Diseases provided significant grants for HIV clinical studies in the U.S. However, long timeline and high costs associated with clinical trials can hamper the market growth. Moreover, regulatory hurdles and ethical issues pertaining to patient safety can hamper the growth of the HIV clinical trials market. Emerging nations like China and India with lower costs for clinical research could generate lucrative opportunities for market players in the near future.
Key Features of the Study
This report provides in-depth analysis of the global HIV clinical trials market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players like Gilead Sciences, Inc., Johnson & Johnson, Merck & Co., Inc., AbbVie Inc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, Pfizer Inc., Roche Holding AG, Sanofi S.A., Novartis AG, Astellas Pharma Inc., Boehringer Ingelheim GmbH, Vertex Pharmaceuticals Incorporated, Amgen Inc., and Takeda Pharmaceutical Company Limited
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global HIV clinical trials market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global HIV clinical trials market
Market Segmentation
- Phase Insights (Revenue, USD Bn, 2019 - 2031)
- Phase I
- Phase II
- Phase III
- Phase IV
- Preclinical
- Study Design Insights (Revenue, USD Bn, 2019 - 2031)
- Interventional Studies
- Observational Studies
- Expanded Access Studies
- Sponsor Type Insights (Revenue, USD Bn, 2019 - 2031)
- Pharmaceutical & Biotechnology Companies
- Academic Research Institutes
- Government & Private Research Organizations
- Contract Research Organizations (CROs)
- Indication Insights (Revenue, USD Bn, 2019 - 2031)
- HIV-1
- HIV-2
- Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Gilead Sciences, Inc.
- Johnson & Johnson
- Merck & Co., Inc.
- AbbVie Inc.
- Bristol-Myers Squibb Company
- GlaxoSmithKline plc
- Pfizer Inc.
- Roche Holding AG
- Sanofi S.A.
- Novartis AG
- Astellas Pharma Inc.
- Boehringer Ingelheim GmbH
- Vertex Pharmaceuticals Incorporated
- Amgen Inc.
- Takeda Pharmaceutical Company Limited
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global HIV Clinical Trials Market, By Phase
- Global HIV Clinical Trials Market, By Study Design
- Global HIV Clinical Trials Market, By Sponsor Type
- Global HIV Clinical Trials Market, By Indication
- Global HIV Clinical Trials Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global HIV Clinical Trials Market, By Phase, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Phase I
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Phase II
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Phase III
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Phase IV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Preclinical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
5. Global HIV Clinical Trials Market, By Study Design, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Interventional Studies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Observational Studies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Expanded Access Studies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global HIV Clinical Trials Market, By Sponsor Type, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Pharmaceutical & Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Academic Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Government & Private Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global HIV Clinical Trials Market, By Indication, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- HIV-1
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- HIV-2
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global HIV Clinical Trials Market, By Region, 2019 - 2031, (USD Bn)
- Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Phase, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Study Design, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Sponsor Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Phase, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Study Design, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Sponsor Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Phase, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Study Design, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Sponsor Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Phase, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Study Design, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Sponsor Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Phase, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Study Design, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Sponsor Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Phase, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Study Design, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Sponsor Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, (USD Bn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Gilead Sciences, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bristol-Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Roche Holding AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis AG
- Astellas Pharma Inc.
- Boehringer Ingelheim GmbH
- Vertex Pharmaceuticals Incorporated
- Amgen Inc.
- Takeda Pharmaceutical Company Limited
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
到 2030 年In Silico临床试验市场预测：按类型、模拟类型、治疗方法、技术、应用、最终用户和地区进行的全球分析
临床试验材料和耗材市场规模、份额、成长分析，按服务、按阶段、按类型、按治疗领域、按地区 - 行业预测，2025-2032
2024-2032 年日本临床试验管理系统市场报告（按组件、部署模式、最终用户和地区）
HIV 临床试验市场：按阶段、试验设计、介入类型、市场参与企业、赞助商 – 2025-2030 年全球预测
HIV 临床试验市场规模、份额、趋势分析报告：按阶段、试验设计、申办者、地区、细分市场预测，2025-2030 年
In Silico 临床试验市场规模、份额、趋势分析报告：按行业、治疗领域、阶段、地区和细分市场预测，2025-2030 年
临床试验市场 - 全球产业规模、份额、趋势、机会和预测，按类型、阶段、研究设计、适应症、最终用户、地区和竞争细分，2019-2029F
基于体学的临床试验市场规模、份额和趋势分析报告：2025-2030 年按阶段、研究设计、适应症、地区和细分市场进行的预测
In Silico临床试验市场：按治疗领域、阶段、产业划分 - 2025-2030 年全球预测
临床实验现场管理组织市场：按阶段、服务、治疗领域和最终用户 - 2025-2030 年全球预测